Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for post-hospitalisation behavioural change in preschool children after day-case surgery
ACTRN12616000096459Phase 3Completed
- Sponsor
- Dr Paul Lee-Archer
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Post-hospitalization behavioral change (PHBC) (3 arms), sponsored by Dr Paul Lee-Archer. Primary endpoints: Negative behaviours measured by the Post Hospitalisation Behaviour Questionnaire for Ambulatory Surgery and Negative behaviours measured by the Strengths and Difficulties Questionnaire. Started Feb 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Post-hospitalization behavioral change (PHBC)
Beyond the preview
Go deeper on ACTRN12616000096459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000096459.